Rocket Lab USA, Inc.

Fundamentals6.0
Price Action6.0
News Sentiment7.0
AI Rating
6.0

Key Drivers

  • Net cash surplus
  • Negative profitability
  • Sky-high multiples

AI
AI Summary

6.0

Rocket Lab has evolved into a defense-backed, diversified aerospace contractor with improving margins and a multi-billion backlog that materially upsides the stock — but the investment hinges on binary Neutron execution and a sustainable cash-flow inflection (else rich valuation risks steep downside).

DefenseBacklog
NeutronRisk
ExecutionCash‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Net cash surplus
  • Negative profitability
  • Sky-high multiples

RKLB has ample cash and low leverage but suffers persistent losses and negative FCF amid improving quarterly margins while trading at extremely stretched valuation.

overvalued
liquidity

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below last-month average
  • 66–68 support
  • 71–72 resistance

Price shows short-term weakness—closing below the last-month (~$70.7) average at $67.23, trading near $66–$68 support with immediate resistance at $71–$72 and a prior rejection at $78.59 that risks further downside if $66 breaks.

vulnerable
rangebound
Support Level: $66–$68
Resistance Level: $71–$72 (strong cap $78.59)

Sharp rejection at $78.59 on 2026-03-17 followed by drop to $67.23 on 2026-03-20

Sentiment & News

7.0

Key News Insights:

  • Backlog surge
  • Neutron delay
  • Funding dilution

Rocket Lab shows strong commercial and defense revenue momentum and a $1.85B backlog driving multi‑year growth, but remains unprofitable with Neutron delays and a large stock offering raising dilution risk.

momentum
dilution

Revenue and backlog wins support upside potential, but Neutron setbacks and the ~$1B equity raise raise near‑term volatility and dilution risk for the stock